News Image

Exploring the Growth Potential of NASDAQ:PGNY as It Nears a Breakout.

By Mill Chart

Last update: Jan 4, 2024

In this article we will dive into PROGYNY INC (NASDAQ:PGNY) as a possible candidate for growth investing. Investors should always do their own research, but we noticed PROGYNY INC showing up in our strong growth, ready to breakout screen, which makes it worth to investigate a bit more.

How We Gauge Growth for NASDAQ:PGNY

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:PGNY boasts a 8 out of 10:

  • PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
  • PGNY shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.53%.
  • The Revenue has been growing by 74.52% on average over the past years. This is a very strong growth!
  • Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 45.53% on average per year.
  • PGNY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.58% yearly.

Assessing Health Metrics for NASDAQ:PGNY

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:PGNY, the assigned 8 reflects its health status:

  • PGNY has an Altman-Z score of 12.37. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.37, PGNY belongs to the top of the industry, outperforming 96.49% of the companies in the same industry.
  • PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 3.16 indicates that PGNY has no problem at all paying its short term obligations.
  • PGNY's Current ratio of 3.16 is amongst the best of the industry. PGNY outperforms 88.60% of its industry peers.
  • A Quick Ratio of 3.16 indicates that PGNY has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.16, PGNY belongs to the best of the industry, outperforming 88.60% of the companies in the same industry.

Understanding NASDAQ:PGNY's Profitability

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:PGNY has achieved a 6:

  • Looking at the Return On Assets, with a value of 7.16%, PGNY belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.09%, PGNY is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
  • PGNY's Return On Invested Capital of 7.66% is fine compared to the rest of the industry. PGNY outperforms 78.07% of its industry peers.
  • The last Return On Invested Capital (7.66%) for PGNY is above the 3 year average (6.26%), which is a sign of increasing profitability.
  • PGNY's Profit Margin of 5.03% is amongst the best of the industry. PGNY outperforms 82.46% of its industry peers.
  • PGNY's Operating Margin of 5.00% is fine compared to the rest of the industry. PGNY outperforms 64.91% of its industry peers.
  • PGNY's Gross Margin has improved in the last couple of years.

How does the Setup look for NASDAQ:PGNY

Besides the Technical Rating, ChartMill assigns a Setup Rating to every stock to determine the degree of consolidation. This rating, ranging from 0 to 10, is updated daily and evaluates various short-term technical indicators. NASDAQ:PGNY currently holds a 7 as its setup rating, suggesting a particular level of consolidation in the stock.

Besides having an excellent technical rating, PGNY also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 37.95. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 34.64, a Stop Loss order could be placed below this zone.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

Our latest full fundamental report of PGNY contains the most current fundamental analsysis.

Our latest full technical report of PGNY contains the most current technical analsysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

PROGYNY INC

NASDAQ:PGNY (4/18/2024, 7:13:59 PM)

Premarket: 31.77 -0.11 (-0.35%)

31.88

-0.87 (-2.66%)

PGNY News

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

News Imagea month ago - ProgynyProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Imagea month ago - BusinessInsiderThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

News Imagea month ago - ProgynyProgyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Seeking AlphaProgyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program
News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Market News VideoWednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

PGNY Links
Follow us for more